Pharmacokinetics of sublingual sufentanil tablets and efficacy and safety in the
management of postoperative pain.
Author(s): Minkowitz HS(1), Singla NK, Evashenk MA, Hwang SS, Chiang YK, Hamel LG, Palmer
PP.
Affiliation(s): Author information:
(1)Memorial Hermann Memorial City Medical Center, Houston, TX, USA.
Publication date & source: 2013, Reg Anesth Pain Med. , 38(2):131-9
BACKGROUND AND OBJECTIVES: A sublingual sufentanil tablet is being developed as a
potential alternative to intravenous (IV) opioids for the management of
postoperative pain. The objective of these studies was to evaluate the
pharmacokinetics, efficacy, and safety of sublingual sufentanil tablets for
postoperative pain management.
METHODS: The pharmacokinetics of sublingual sufentanil 10 and 80 µg were compared
with IV sufentanil in 12 subjects in a phase 1 study. The safety and efficacy of
sublingual sufentanil (5-15 µg) were evaluated in double-blind, randomized,
placebo-controlled phase 2 studies in patients undergoing knee replacement
surgery (n = 101) or open abdominal (ABD) surgery (n = 94). The primary efficacy
measurement was the summed pain intensity difference compared with baseline over
12 hours (SPID-12).
RESULTS: Sublingual sufentanil pharmacokinetics were dose proportional following
single doses of 10 and 80 µg. Plasma half-time (time from peak plasma
concentration to 50% of peak concentration) was 80 to 90 minutes for sublingual
sufentanil compared with 15 minutes or less for IV sufentanil. In the phase 2
studies, greater SPID-12 scores (ie, lower pain intensity) compared with placebo
were observed for sublingual sufentanil 15 µg in the knee replacement study (P <
0.05) and for 10 and 15 µg in the ABD study (P < 0.01). All doses of sublingual
sufentanil were well tolerated, and the incidence of adverse events was similar
between the sublingual sufentanil and placebo groups.
CONCLUSIONS: Sufentanil formulated as a sublingual solid dosage form provides a
duration of action that allows effective analgesia for postoperative patients in
a medically supervised setting.
|